Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIconic Labs Regulatory News (ICON)

  • This share is currently suspended. It was suspended at a price of 5.375

Share Price Information for Iconic Labs (ICON)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.375
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 5.375
ICON Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New project – Infotagion Covid-19

30 Mar 2020 07:30

RNS Number : 0064I
Iconic Labs PLC
30 March 2020
 

 

30th March 2020

Iconic Labs Plc ("Iconic Labs" or the "Company")

New project - Infotagion Covid-19

 

Iconic Labs Plc (LSE:ICON) (the "Company"), a multi-divisional new media and technology business, is pleased to provide the following update.

Infotagion: Covid-19

The Company announces that, in partnership with Damian Collins MP, former Chair of the Digital, Culture, Media and Sport select committee, who also led the inquiries on disinformation and fake news, it has established 'Infotagion: Covid-19'. Infotagion: Covid-19 is an independent online and social media expert fact checking service to combat disinformation about the Covid-19 pandemic and its related economic and social effects, that are spreading through social media.

This service is being provided on a not for profit basis and is supported by people who believe that in the age of information contagion we need to help the truth fight back against the virus. The aim of Infotagion is to combat fake news which can cause misinformation, and panic and potentially cause governments and health services to divert resources away from where they are needed most.

Backers of Infotagion so far include a cross party group of current and former parliamentarians, members of the House of Lords and a range of campaigners, academics and celebrities from across the world.

The service is completely free to access and its core message is, "If you see something that doesn't look right, check it on Infotagion or share it with us and we'll verify the facts from trusted sources of information."

The core of the service is a website (www.infotagion.com), designed by Lovegunn, an award-winning design agency,  on which users post screenshots of information which they have received from social media or elsewhere. The submitted information is checked by a team organised by Mr Collins, including academic experts in identifying disinformation, and using the latest public health information provided by trust sources including from the UK parliament, governments and the WHO. The website then gives "traffic light answers" as to whether the information is correct, and provides links to trusted information sources, such as WHO or government websites, and, in some cases, a short explanation.

The site should therefore provide an interactive, trusted source of information and verification within the social media and wider communities. The Company will then use its extensive contacts within both the media and social media industry and among the influencer community to promote this source of accurate information for the benefit of all.

Liam Harrington, Chief Business Officer of Iconic Labs said: "Social media is proving to be a very powerful and important asset to our communities in the current crisis. In particular it provides one of the most effective means by which people can maintain essential interaction with others, and preserve communities, during this period of social distancing and isolation.

"However, there is another side in that social medial is one of the primary forums in which disinformation, whether circulated innocently or deliberately, is prevalent. We are therefore very pleased to be able to play a role in helping to counter disinformation about the current Covid-19 pandemic by bringing our expertise and skills to bear on the problem."

 

John Quinlan, Chief Executive Officer of Iconic Labs said: "At a time where people are being able to volunteer to help where they can, we are delighted to be able to use our skills and contacts where they will be most useful. For Infotagion to have received such widespread support and backing so quickly is really encouraging and hopefully it will be able to help the authorities and the public at this challenging time. "

 

Damian Collins MP, said: "The spread of disinformation through social media is particularly dangerous, and so I am very pleased that David Sefton introduced me to John, Liam, Sam and the whole Iconic Labs team, whose background experience at UNILAD is exceptional, and who I believe can play a key role with the social media world and elsewhere online in helping to dispel disinformation and disseminate correct information."

 

 

Market Abuse Regulation (MAR) Disclosure

The information contained within this announcement is deemed by the Company to constitute inside information for the purposes of the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

Iconic Labs Plc (LSE:ICON), is a multi-divisional new media and technology business set up by Liam Harrington, John Quinlan and Sam Asante. The initial focus is to expand the content platform, suite of digital brands, and technology products both organically and through acquisitions in addition to consultancy and agency services.

**ENDS**

 

For further information, please visit the Company's website www.iconiclabs.co.uk or contact:

 

Damon Heath

Shard Capital Partners LLP

Tel: +44 (0) 20 7186 9950

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDEASDEDSPEEEA
Date   Source Headline
28th Mar 20247:00 amRNSInterim Results
11th Mar 202412:00 pmRNSHeads of Terms Signed
29th Feb 20247:00 amRNSTotal Voting Rights
29th Feb 20247:00 amRNSSuspension of Trading
13th Feb 20242:08 pmRNSResult of AGM
7th Feb 20249:10 amRNSConversion of Notes and Allotment of Shares
19th Jan 20243:49 pmRNSNotice of AGM
4th Jan 20247:00 amRNSBoard Changes & Business and Strategy Update
29th Dec 20237:00 amRNSTotal Voting Rights
7th Dec 20238:53 amRNSConversion of Securities
4th Dec 20237:53 amRNSConversion of Securities
30th Nov 20237:00 amRNSTotal Voting Rights
17th Nov 202311:32 amRNSConversion of Securities
13th Nov 20238:40 amRNSConversion of Securities
2nd Nov 202310:35 amRNSConversion of Securities
31st Oct 20239:29 amRNSTotal Voting Rights
31st Oct 20237:00 amRNSFull Year Results for the Year ended 30 June 2023
24th Oct 20235:31 pmRNSChange of Auditor
17th Oct 20237:51 amRNSConversion of Securities
13th Oct 202311:32 amRNSAnnouncement of the Completion of CVA
13th Oct 202311:30 amRNSConversion of Securities
29th Sep 20238:01 amRNSTotal Voting Rights
22nd Sep 20239:40 amRNSConversion of Securities
18th Sep 20236:27 pmRNSConversion of Notes – Replacement
18th Sep 20237:37 amRNSConversion of Securities
12th Sep 20238:45 amRNSStatement re CVA
4th Sep 202312:02 pmRNSConversion of Securities
31st Aug 20237:21 amRNSTotal Voting Rights
25th Aug 20234:49 pmRNSResult of AGM
18th Aug 20237:51 amRNSConversion of Securities
14th Aug 20237:59 amRNSIssue of Debt
8th Aug 20232:58 pmRNSPublication of a Prospectus
4th Aug 20234:19 pmRNSNotice of AGM
30th Jun 20239:12 amRNSTotal Voting Rights
2nd Jun 20231:20 pmRNSIssue of Equity
28th Apr 202310:35 amRNSTotal Voting Rights
12th Apr 20238:13 amRNSConversion of Securities
31st Mar 20233:11 pmRNSTotal Voting Rights
31st Mar 20231:59 pmRNSHalf-year Report
29th Mar 20232:05 pmRNSSecond Price Monitoring Extn
29th Mar 20232:00 pmRNSPrice Monitoring Extension
28th Mar 20237:42 amRNSConversion of Securities
27th Mar 202311:05 amRNSSecond Price Monitoring Extn
27th Mar 202311:00 amRNSPrice Monitoring Extension
22nd Mar 202311:48 amRNSSubscription of Convertible Notes
21st Mar 202311:05 amRNSSecond Price Monitoring Extn
21st Mar 202311:00 amRNSPrice Monitoring Extension
21st Mar 20239:05 amRNSSecond Price Monitoring Extn
21st Mar 20239:00 amRNSPrice Monitoring Extension
20th Mar 20234:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.